Iatrogenic botulism after the therapeutic use of botulinum toxin-A: A case report and review of the literature

Clinical Neuropharmacology

Volumn 35, Issue 5, 2012, Pages 254-257

  Ghasemi, Majid ^a   Norouzi, Rasul ^b   Salari, Mehri ^a   Asadi, Bahador ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c AJA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Botox; botulinum toxin A; hyperhidrosis; iatrogenic botulism

Indexed keywords

BOTULINUM TOXIN A; PYRIDOSTIGMINE;

ADULT; ARTICLE; BOTULISM; BULBAR PARALYSIS; CASE REPORT; DYSPHAGIA; DYSPNEA; ELECTROMYOGRAPHY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; HYPERHIDROSIS; IATROGENIC DISEASE; LIMB WEAKNESS; MUSCLE ACTION POTENTIAL; MUSCLE DENERVATION; NERVE STIMULATION; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL;

ADULT; BOTULINUM TOXINS, TYPE A; BOTULISM; FEMALE; HUMANS; IATROGENIC DISEASE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84866539209     PISSN: 03625664     EISSN: 1537162X     Source Type: Journal    
DOI: 10.1097/WNF.0b013e31826248b8     Document Type: Article

References (25)

1. Stolman LP. Treatment of hyperhidrosis. Dermatol Clin 1998;16:863-869.
2. Aghaei S. Botulinum toxin therapy for palmar hyperhidrosis: experience in an Iranian population. Int J Dermatol 2007;46:212-214. (Pubitemid 46671705)
3. Bushara KO, Park DM, Jones JC, et al. Botulinum toxinVa possible new treatment for axillary hyperhidrosis. Clin Exp Dermatol 1996;21:276-278. (Pubitemid 26380193)
4. Naver H, Swartling C, Aquilonius SM. Treatment of focal hyperhidrosis with botulinum toxin type A. Brief overview of methodology and 2 years' experience. Eur J Neurol 1999;6:s117Ys120.
5. Coban A, Matur Z, Hanagasi HA, et al. Iatrogenic botulism after botulinum toxin type A injections. Clin Neuropharmacol 2010;33:158-160.
6. Glogau RG, Botulinum A. neurotoxin for axillary hyperhidrosis. No sweat Botox. Dermatol Surg 1998;24(8):817-819. (Pubitemid 28405012)
7. Naumann M, Hofmann U, Bergmann I, et al. Focal hyperhidrosis: effective treatment with intracutaneous botulinum toxin. Arch Dermatol 1998;134:301-304. (Pubitemid 28141617)
8. Heckmann M, Ceballos-Baumann AO, Plewig G. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med 2001;344:488-493. (Pubitemid 32164900)
9. Lowe NJ, Glaser DA, Eadie N, et al. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: A 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety. J Am Acad Dermatol 2007;56:604-611. (Pubitemid 46400197)
10. Rossi RP, Strax TE, Di Rocco A. Severe dysphagia after botulinum toxin B injection to the lower limbs and lumbar paraspinal muscles. Am J Phys Med Rehabil 2006;85:1011-1013. (Pubitemid 44789618)
11. Odderson IR. Axillary hyperhidrosis: Treatment with botulinum toxin A. Arch Phys Med Rehabil 1998;79:350-352. (Pubitemid 28207128)
12. Shelley W, Talanin N, Shelley E. Botulinum toxin therapy for palmar hyperhidrosis. J Am Acad Dermatol 1998;38:227-229. (Pubitemid 28100837)
13. Karamfilov T, Konrad H, Karte K, et al. Lower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase. Arch Dermatol 2000;136:487-490. (Pubitemid 30212960)
14. Coté TR, Mohan AK, Polder JA, et al. Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol 2005;53:407-415. (Pubitemid 41195960)
15. Pena MA, Alam M, Yoo SS. Complications with the use of botulinum toxin type A for cosmetic applications and hyperhidrosis. Semin Cutan Med Surg 2007;26:29-33. (Pubitemid 46349780)
16. Wollina U, Karamfilov T, Konrad H. High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval. J Am Acad Dermatol 2002;46:536-540.
17. Shapiro RL, Hatheway C, Swerdlow DL. Botulism in the United States: A clinical and epidemiologic review. Ann Intern Med 1998;129:221-228. (Pubitemid 28377513)
18. Cherington M. Clinical spectrum of botulism. Muscle Nerve 1998; 21:701-710. (Pubitemid 28248674)
19. Pascuzzi RM. Drugs and toxins associated with myopathies. Curr Opin Rheumatol 1998;10:511-520. (Pubitemid 28508744)
20. Müller Vahl KR, Kolbe H, Egensperger R, et al. Mitochondriopathy, blepharospasm, and treatment with botulinum toxin. Muscle Nerve 2000;23:647-648. (Pubitemid 30164794)
21. Jankovic J, Schwartz KS. Clinical correlates of response to botulinum toxin injections. Arch Neurol 1991;48:1253-1256.
22. Garner C, Straube A,Witt T, et al. Time course of distant effects of local injections of botulinum toxin. Mov Disord 1993;8:33-37. (Pubitemid 23039227)
23. Simonetta Moreau M, Cauhepe C, Magues J, et al. A double-blind, randomized, comparative study of Dysport\ vs. Botox\ in primary palmar hyperhidrosis. Br J Dermatol 2003;149:1041-1045. (Pubitemid 37541992)
24. Heckmann M, Breit S, Ceballos-Baumann A, et al. Axilläre Hyperhidrose: Erfolgreiche Behandlung mit Botulinumtoxin-A. Der Hautarzt 1998;49:101-103. (Pubitemid 28116519)
25. Klein AW. Complications with the use of botulinum toxin. Dermatol Clin 2004;22:197-206.